303 related articles for article (PubMed ID: 25926289)
1. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
Lee MG; Lee YH
Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
[TBL] [Abstract][Full Text] [Related]
2. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.
Zhu QQ; Zhang XL; Zhang SM; Tang SW; Min HY; Yi L; Xu B; Song Y
Medicine (Baltimore); 2015 Oct; 94(43):e1901. PubMed ID: 26512610
[TBL] [Abstract][Full Text] [Related]
3. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
Borie R; Crestani B; Dieude P; Nunes H; Allanore Y; Kannengiesser C; Airo P; Matucci-Cerinic M; Wallaert B; Israel-Biet D; Cadranel J; Cottin V; Gazal S; Peljto AL; Varga J; Schwartz DA; Valeyre D; Grandchamp B
PLoS One; 2013; 8(8):e70621. PubMed ID: 23940607
[TBL] [Abstract][Full Text] [Related]
4. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
Wu X; Li W; Luo Z; Chen Y
Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
[TBL] [Abstract][Full Text] [Related]
5. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the promoter
Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
[TBL] [Abstract][Full Text] [Related]
7. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
[TBL] [Abstract][Full Text] [Related]
8. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
[TBL] [Abstract][Full Text] [Related]
9. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
[TBL] [Abstract][Full Text] [Related]
10. A
Verma A; Minnier J; Wan ES; Huffman JE; Gao L; Joseph J; Ho YL; Wu WC; Cho K; Gorman BR; Rajeevan N; Pyarajan S; Garcon H; Meigs JB; Sun YV; Reaven PD; McGeary JE; Suzuki A; Gelernter J; Lynch JA; Petersen JM; Zekavat SM; Natarajan P; Dalal S; Jhala DN; Arjomandi M; Gatsby E; Lynch KE; Bonomo RA; Freiberg M; Pathak GA; Zhou JJ; Donskey CJ; Madduri RK; Wells QS; Huang RDL; Polimanti R; Chang KM; Liao KP; Tsao PS; Wilson PWF; Hung AM; O'Donnell CJ; Gaziano JM; Hauger RL; Iyengar SK; Luoh SW;
Am J Respir Crit Care Med; 2022 Nov; 206(10):1220-1229. PubMed ID: 35771531
[No Abstract] [Full Text] [Related]
11. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
[TBL] [Abstract][Full Text] [Related]
13. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.
Wei R; Li C; Zhang M; Jones-Hall YL; Myers JL; Noth I; Liu W
Transl Res; 2014 May; 163(5):494-502. PubMed ID: 24434656
[TBL] [Abstract][Full Text] [Related]
14. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
[TBL] [Abstract][Full Text] [Related]
16. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
[TBL] [Abstract][Full Text] [Related]
17. Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility.
Shi X; Ma Y; Li H; Yu H
BMC Med Genet; 2020 Apr; 21(1):71. PubMed ID: 32252656
[TBL] [Abstract][Full Text] [Related]
18. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
Transpl Int; 2022; 35():10159. PubMed ID: 35651878
[TBL] [Abstract][Full Text] [Related]
19. A common MUC5B promoter polymorphism and pulmonary fibrosis.
Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
[TBL] [Abstract][Full Text] [Related]
20.
Joo YB; Ahn SM; Bang SY; Park Y; Hong SJ; Lee Y; Cho SK; Choi CB; Sung YK; Kim TH; Jun JB; Yoo DH; Bae SC; Lee HS
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
